Back
Disc Medicine Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Buy
72
IRON
Disc Medicine
Last Price:
44.30
Seasonality Move:
-19.23%
Buy
53
ALNY
Alnylam Pharmaceuticals
Last Price:
247.10
Seasonality Move:
20.36%
Buy
72
Disc Medicine (IRON)
is a Buy
Is Disc Medicine a Buy, Sell or Hold?
- The current Disc Medicine [IRON] share price is $43.41. The Score for IRON is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
- IRON is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
53
Alnylam Pharmaceuticals (ALNY)
is a Buy
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $245.36. The Score for ALNY is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- ALNY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
IRON Stock Price Chart
What is Disc Medicine's stock price today?
-
The Disc Medicine share price today is $43.41
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IRON is experiencing slight selling pressure.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $245.36
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing slight buying pressure.
IRON Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.71 | Buy |
| Relative Strength Index (14 RSI): | 61.15 | Buy |
| Chaikin Money Flow: | -59334 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (34.25 - 43.01) | Buy |
| Bollinger Bands (100): | (29.85 - 62.39) | Sell |
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 17.47 | Buy |
| Relative Strength Index (14 RSI): | 90.5 | Buy |
| Chaikin Money Flow: | 1048690 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (135.66 - 190.7) | Buy |
| Bollinger Bands (100): | (139.26 - 170.88) | Buy |
IRON Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 44.14 | Sell |
| 20-day SMA: | 39.95 | Buy |
| 50-day SMA: | 34.11 | Buy |
| 200-day SMA: | 49.95 | Sell |
| 8-day EMA: | 43.21 | Buy |
| 20-day EMA: | 40.49 | Buy |
| 50-day EMA: | 39.2 | Buy |
| 200-day EMA: | 45.1 | Sell |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 187.89 | Buy |
| 20-day SMA: | 166.59 | Buy |
| 50-day SMA: | 155.67 | Buy |
| 200-day SMA: | 165.59 | Buy |
| 8-day EMA: | 200.52 | Buy |
| 20-day EMA: | 176.3 | Buy |
| 50-day EMA: | 162.56 | Buy |
| 200-day EMA: | 166.54 | Buy |
Disc Medicine Earnings Growth & IRON Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.36 per share, a decrease next quarter of $0.17 per share, a decrease this year of $1.55 per share, and a decrease next year of $0.38 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.32 per share, a decrease next quarter of $0.12 per share, a decrease this year of $0.46 per share, and an increase next year of $1.83 per share.
Disc Medicine Technical Analysis
| Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Alnylam Pharmaceuticals Technical Analysis
| Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||